Progression of salivary gland dysfunction in patients with Sjogren's syndrome
- PMID: 16728458
- PMCID: PMC1798390
- DOI: 10.1136/ard.2006.052647
Progression of salivary gland dysfunction in patients with Sjogren's syndrome
Abstract
Background: Salivary gland dysfunction is one of the key manifestations of Sjögren's syndrome.
Objectives: (1) To assess prospectively loss of function of individual salivary glands in patients with primary and secondary Sjögren's syndrome in relation to disease duration and use of immunomodulatory drugs. (2) To study changes in sialochemical and laboratory values and subjective complaints over time.
Methods: 60 patients with Sjögren's syndrome were included in this study. Whole and gland-specific saliva (parotid and submandibular/sublingual (SM/SL)), samples were collected at baseline and after a mean of 3.6 (SD 2.3) years of follow-up. Disease duration was recorded for all patients.
Results: Patients with Sjögren's syndrome with short disease duration had significantly higher stimulated flow rates at baseline than those with longer disease duration (p<0.05). When compared with healthy controls, the decrease in SM/SL flow rates at baseline was more prominent than that in parotid flow rates (p<0.05). Over time, there was a significant further decrease of stimulated flow rates, especially of the parotid gland, accompanied by increasing problems with swallowing dry food (p<0.05). The decrease was independent of the use of corticosteroids or disease-modifying antirheumatic drugs (DMARDs). Sialochemical variables remained stable.
Conclusions: Early Sjögren's syndrome is characterised by a decreased salivary gland function (parotis>SM/SL), which shows a further decrease over time, regardless of the use of DMARDs or steroids. Patients with Sjögren's syndrome with longer disease duration are characterised by severely reduced secretions of both the parotid and SM/SL glands. These observations are relevant for identifying patients who would most likely benefit from intervention treatment.
Conflict of interest statement
Competing interests: None.
Similar articles
-
Sialometry and sialochemistry: a non-invasive approach for diagnosing Sjögren's syndrome.Ann Rheum Dis. 2002 Feb;61(2):137-44. doi: 10.1136/ard.61.2.137. Ann Rheum Dis. 2002. PMID: 11796400 Free PMC article.
-
Comparison of lacrimal and salivary gland involvement in Sjögren's syndrome.Arch Otolaryngol Head Neck Surg. 2003 Sep;129(9):966-71. doi: 10.1001/archotol.129.9.966. Arch Otolaryngol Head Neck Surg. 2003. PMID: 12975269
-
Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome.Ann Rheum Dis. 2001 Dec;60(12):1110-6. doi: 10.1136/ard.60.12.1110. Ann Rheum Dis. 2001. PMID: 11709452 Free PMC article.
-
Salivary gland dysfunction and xerostomia in Sjögren's syndrome.Oral Maxillofac Surg Clin North Am. 2014 Feb;26(1):35-53. doi: 10.1016/j.coms.2013.09.003. Oral Maxillofac Surg Clin North Am. 2014. PMID: 24287192 Review.
-
Salivary gland function in Sjögren's syndrome: a review.Br Dent J. 1973 Nov 6;135(9):393-9. doi: 10.1038/sj.bdj.4803096. Br Dent J. 1973. PMID: 4607042 Review. No abstract available.
Cited by
-
Treatment of non-systemic Sjögren's syndrome: Potential prevention of systematization with immunosuppressant agent/biotherapy.J Transl Autoimmun. 2024 Mar 3;8:100238. doi: 10.1016/j.jtauto.2024.100238. eCollection 2024 Jun. J Transl Autoimmun. 2024. PMID: 38496268 Free PMC article.
-
Longevity of dental restorations in Sjogren's disease patients using electronic dental and health record data.BMC Oral Health. 2024 Feb 7;24(1):203. doi: 10.1186/s12903-024-03957-9. BMC Oral Health. 2024. PMID: 38326771 Free PMC article.
-
Exploratory Analysis of Objective Outcome Measures for the Clinical Assessment of Erosive Tooth Wear.Diagnostics (Basel). 2023 Aug 2;13(15):2568. doi: 10.3390/diagnostics13152568. Diagnostics (Basel). 2023. PMID: 37568931 Free PMC article.
-
Rapidly Enlarging Parotid Mass in a Person Living with HIV: A Case of Multiple Myeloma with Extramedullary Plasmacytoma.Am J Case Rep. 2023 Aug 3;24:e938431. doi: 10.12659/AJCR.938431. Am J Case Rep. 2023. PMID: 37533236 Free PMC article.
-
Use and efficacy of dry-mouth interventions in Sjögren's disease patients and possible association with perceived oral dryness and patients' discomfort.Clin Oral Investig. 2023 Sep;27(9):5529-5537. doi: 10.1007/s00784-023-05172-2. Epub 2023 Jul 28. Clin Oral Investig. 2023. PMID: 37507599 Free PMC article.
References
-
- Mignogna M D, Fedele S, Russo L L, Lo Muzio L, Wolff A. Sjögren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia. J Oral Pathol Med 2005341–6. - PubMed
-
- Thorn J J, Prause J U, Oxholm P. Sialochemistry in Sjögren's syndrome: a review. J Oral Pathol Med 198918457–468. - PubMed
-
- Veerman E C I, Van den Keybus P A, Vissink A, Nieuw Amerongen A V. Human glandular salivas: their separate collection and analysis. Eur J Oral Sci 1996104346–352. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical